对异常m6ARNA修饰的全面分析确定了非小细胞肺癌的预后生物标志物
Yifei Li1, Peng Jiao2, Donghang Li2
1Clinical Biobank, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China.
International journal of medical sciences
|November 10, 2025
概括
在非小细胞肺癌 (NSCLC) 中,N6-甲基氨酸 (m6A) RNA 修饰失调,瘤组织显示m6A密度降低. 这些通过直接RNA测序识别的表观遗传变化为NSCLC提供了潜在的新治疗点.
科学领域:
- 表观遗传学和分子生物学
- 在瘤学瘤学.
- 基因组学就是基因组学.
背景情况:
- N6-甲基氨酸 (m6A) RNA修饰失调与非小细胞肺癌 (NSCLC) 的发展和进展有关.
- 了解m6A景观对于识别NSCLC中新的治疗策略至关重要.
研究的目的:
- 在NSCLC中使用直接RNA纳米孔测序 (dRNA-seq) 全面地绘制和分析m6A修饰景观.
- 与正常组织相比,在NSCLC中识别差异甲基化m6A位点和相关基因.
- 研究NSCLC中m6A修饰和调节者的预后意义.
主要方法:
- 直接RNA纳米孔测序 (dRNA-seq) 用于比较NSCLC和相邻正常组织之间的m6A模式.
- 不同甲基化分析确定了数千个m6A位点,将它们分类为高甲基化或低甲基化.
- 进行了功能丰富分析和与TCGA临床数据的相关性,以评估生物和预后影响.
主要成果:
- 与正常组织相比,NSCLC组织的m6A密度降低,具有明显的差异化甲基化模式.
- 像SOX2和TOP2A这样的上调基因显示出低甲基化m6A修饰;高甲基化基因与DNA复制和转录有关,而低甲基化基因与细胞迁移和MAPK信号相关.
- m6A调节者的表达在NSCLC亚型中一致,m6A相关的差异表达基因 (DEGs) 显示出预后意义.
结论:
- m6ARNA修饰在NSCLC的发病过程中发挥着关键作用.
- dRNA-seq是一个强大的工具,用于发现癌症中的RNA表观遗传变化.
- 鉴定到的m6A修饰和相关基因代表了NSCLC的潜在新型治疗点.
更多相关视频
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.8K
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
11.6K
相关概念视频
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
02:39lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K